NO20053089D0 - Carbamidsyreestere med anticolinergisk virkning. - Google Patents

Carbamidsyreestere med anticolinergisk virkning.

Info

Publication number
NO20053089D0
NO20053089D0 NO20053089A NO20053089A NO20053089D0 NO 20053089 D0 NO20053089 D0 NO 20053089D0 NO 20053089 A NO20053089 A NO 20053089A NO 20053089 A NO20053089 A NO 20053089A NO 20053089 D0 NO20053089 D0 NO 20053089D0
Authority
NO
Norway
Prior art keywords
carbamic acid
acid esters
action
anticolinergic
relates
Prior art date
Application number
NO20053089A
Other languages
English (en)
Other versions
NO20053089L (no
Inventor
Georg Speck
Michael P Pieper
Matthias Hoffmann
Matthias Grauert
Steffen Breitfelder
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20053089L publication Critical patent/NO20053089L/no
Publication of NO20053089D0 publication Critical patent/NO20053089D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20053089A 2002-11-26 2005-06-23 Carbamidsyreestere med anticolinergisk virkning. NO20053089D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255040A DE10255040A1 (de) 2002-11-26 2002-11-26 Neue Carbaminsäureester mit anticholinerger Wirksamkeit
PCT/EP2003/012912 WO2004048373A1 (de) 2002-11-26 2003-11-19 Carbaminsäureester mit anticholinerger wirksamkeit

Publications (2)

Publication Number Publication Date
NO20053089L NO20053089L (no) 2005-06-23
NO20053089D0 true NO20053089D0 (no) 2005-06-23

Family

ID=32240420

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053089A NO20053089D0 (no) 2002-11-26 2005-06-23 Carbamidsyreestere med anticolinergisk virkning.

Country Status (20)

Country Link
EP (1) EP1567526B1 (no)
JP (1) JP4754829B2 (no)
KR (1) KR20050086821A (no)
CN (1) CN1717408A (no)
AT (1) ATE392424T1 (no)
AU (1) AU2003289880A1 (no)
BR (1) BR0316549A (no)
CA (1) CA2507110C (no)
DE (2) DE10255040A1 (no)
EA (1) EA200500775A1 (no)
EC (1) ECSP055803A (no)
ES (1) ES2304538T3 (no)
HR (1) HRP20050465A2 (no)
MX (1) MXPA05005443A (no)
NO (1) NO20053089D0 (no)
PL (1) PL376638A1 (no)
RS (1) RS20050384A (no)
UA (1) UA81649C2 (no)
WO (1) WO2004048373A1 (no)
ZA (1) ZA200502946B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7358244B2 (en) 2003-05-28 2008-04-15 Theravance, Inc. Azabicycloalkane compounds
TW200534855A (en) * 2004-01-13 2005-11-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
JP2008505118A (ja) * 2004-06-30 2008-02-21 グラクソ　グループ　リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
JP2008520573A (ja) * 2004-11-15 2008-06-19 グラクソ グループ リミテッド 新規ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
EP1904446A2 (en) * 2005-07-11 2008-04-02 Ranbaxy Laboratories Limited Azabicyclo derivatives as muscarinic receptor antagonists
EP1971572A1 (en) * 2005-12-16 2008-09-24 Argenta Discovery Limited Cyclic amine derivatives and their uses
US8367696B2 (en) 2007-02-09 2013-02-05 Astellas Pharma Inc. Aza-bridged-ring compound
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
PT3691620T (pt) 2017-10-05 2022-10-06 Fulcrum Therapeutics Inc Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd
WO2019096226A1 (en) 2017-11-16 2019-05-23 Chengdu Easton Biopharmaceuticals Co., Ltd. Pasylated vegfr/pdgfr fusion proteins and their use in therapy
JP2021505569A (ja) * 2017-12-04 2021-02-18 フリードリヒ−アレクサンダー−ウニヴェルシテート エアランゲン−ニュルンベルク Ｍ２よりもｍ３に対して選択性を有するフルオロフェニル置換ムスカリン受容体リガンド
KR20220001259A (ko) 2020-06-29 2022-01-05 (주)아모레퍼시픽 표면처리된 무기입자, 이의 제조방법, 이의 분산액 및 이를 포함하는 화장료 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759460A (fr) * 1969-11-26 1971-05-26 Knoll Ag Nouveaux carbamates et leur procede de preparation
GB8600978D0 (en) * 1986-01-16 1986-02-19 Beecham Group Plc Compounds
IT1228293B (it) * 1989-02-06 1991-06-07 Angeli Inst Spa Benzoderivati di composti eterociclici contenenti azoto.
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
AU7545894A (en) * 1993-09-02 1995-03-22 Yamanouchi Pharmaceutical Co., Ltd. Carbamate derivative and medicine containing the same
WO1995021820A1 (fr) * 1994-02-10 1995-08-17 Yamanouchi Pharmaceutical Co., Ltd. Nouveau derive du carbamate et composition correspondante
JP2000506896A (ja) * 1996-03-20 2000-06-06 ウェイク フォレスト ユニバーシティ 腫瘍細胞増殖のバイオマーカーとしてのシグマ―２レセプター

Also Published As

Publication number Publication date
ECSP055803A (es) 2005-08-11
JP2006514010A (ja) 2006-04-27
EA200500775A1 (ru) 2005-12-29
NO20053089L (no) 2005-06-23
EP1567526A1 (de) 2005-08-31
CA2507110A1 (en) 2004-06-10
CA2507110C (en) 2012-07-10
DE50309655D1 (de) 2008-05-29
EP1567526B1 (de) 2008-04-16
JP4754829B2 (ja) 2011-08-24
DE10255040A1 (de) 2004-06-03
RS20050384A (en) 2007-12-31
UA81649C2 (ru) 2008-01-25
CN1717408A (zh) 2006-01-04
HRP20050465A2 (en) 2006-10-31
BR0316549A (pt) 2005-10-04
AU2003289880A1 (en) 2004-06-18
ES2304538T3 (es) 2008-10-16
ATE392424T1 (de) 2008-05-15
PL376638A1 (pl) 2006-01-09
ZA200502946B (en) 2005-11-23
KR20050086821A (ko) 2005-08-30
MXPA05005443A (es) 2005-08-03
WO2004048373A1 (de) 2004-06-10

Similar Documents

Publication Publication Date Title
NO20053089D0 (no) Carbamidsyreestere med anticolinergisk virkning.
RS65604A (en) Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
MXPA04006677A (es) Procedimiento para la preparacion de esteres de escopina.
NO20062644L (no) DPP-IV inhibitorer
PL378168A1 (pl) Dihydropterydynony, sposoby ich wytwarzania i ich zastosowanie w postaci leków
MXPA04002067A (es) Nuevas dihidropteridinonas, procedimientos para su preparacion y su uso como medicamento.
DE50304569D1 (de) Xanthencarbonsäureester des tropenols und scopins als m3-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
ATE259779T1 (de) Formoterol-polymorphe
SE0301882D0 (sv) New use I
IL183636A0 (en) Quinoline derivative, use and production thereof, and drug containing the same
MY140164A (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
ATE394379T1 (de) 4-alkoxy-cyclohexan-1-amino-carbonsäureester und verfahren zu ihrer herstellung
MY141020A (en) Novel pparalpha and ppargamma agonists
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
ATE392413T1 (de) Verfahren zur herstellung von beta-alaninamiden
WO2003014094A3 (de) Heterocyclylarylsulfonamide
ATE399779T1 (de) Zwischenprodukte für die herstellung von neuraminidase-inhibitor-konjugaten
MXPA05008862A (es) Heterociclos de nitrogeno n-arilo sustituidos.
RS20050620A (en) Nitrate esters of phenylaminothiophenacetic acid derivatives
BG106916A (en) Method for producing aryl-iminomethyl-carbamic acid esters
SE0402972D0 (sv) Novel compounds
MXPA05011840A (es) Procedimiento para cristalizar sales de guanidinio.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application